Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C.– Expert insights from key FDA and CMS officials highlight the on-demand offerings of Week 3 at The Virtual The MedTech Conference, powered by AdvaMed®, covering topics on the…
100-million-plus antigen tests to be shipped by end of fall WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data…
WASHINGTON, D.C.– Week 2 of The Virtual The MedTech Conference, powered by AdvaMed®, brings an additional slate of on-demand content as the premier meeting of the medical technology community continues its…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
WASHINGTON, D.C. – The Virtual The MedTech Conference, powered by AdvaMed®, kicks off its first week of on-demand content with a slate of informative sessions providing something for everyone in…
WASHINGTON, D.C. – Following today’s issuance by the Centers for Medicare and Medicaid Services (CMS) of a proposed rule on Medicare coverage of innovative technologies, the Advanced Medical Technology Association® (AdvaMed®)…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from Ashley Wittorf, Executive Director, AdvaMed Accel® & Global Head, Investor Relations, on bipartisan legislation (HR 7917) introduced in the…